Get the Stockscreener App
17.80
1.08%
0.19
After Hours:
17.70
-0.10
-0.56%
Overview
News
Price History
Option Chain
Financials
Why KVUE Down?
Discussions
Forecast
Dividend History
Kenvue Inc stock is traded at $17.80, with a volume of 12.56M.
It is up +1.08% in the last 24 hours and down -7.92% over the past month.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
See More
Previous Close:
$17.61
Open:
$17.59
24h Volume:
12.56M
Relative Volume:
0.57
Market Cap:
$34.19B
Revenue:
$15.29B
Net Income/Loss:
$1.62B
P/E Ratio:
21.11
EPS:
0.8433
Net Cash Flow:
$1.82B
1W Performance:
-0.06%
1M Performance:
-7.92%
6M Performance:
+0.79%
1Y Performance:
+10.08%
1-Day Range:
$17.55
$17.84
1-Week Range:
$17.49
$17.99
52-Week Range:
$14.02
$20.13
Kenvue Inc Stock (KVUE) Company Profile
Name
Kenvue Inc
Sector
Industry
Phone
908-874-1200
Address
1 KENVUE WAY, SUMMIT
Compare KVUE vs PG, UL, CL, EL
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
17.80 | 34.19B | 15.29B | 1.62B | 1.82B | 0.8433 |
PG
Procter Gamble Co
|
146.23 | 339.64B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
62.54 | 134.67B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
86.06 | 68.60B | 20.80B | 2.22B | 3.77B | 2.5772 |
EL
Estee Lauder Cos Inc
|
94.47 | 34.18B | 14.85B | -248.00M | 1.29B | -0.6966 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-26 | Downgrade | Jefferies | Buy → Hold |
| Oct-29-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| Sep-26-25 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Apr-10-25 | Initiated | Redburn Atlantic | Neutral |
| Mar-24-25 | Initiated | Evercore ISI | In-line |
| Jan-06-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-12-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Sep-24-24 | Initiated | Jefferies | Buy |
| Sep-24-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-28-24 | Resumed | Citigroup | Neutral |
| Apr-11-24 | Initiated | Bernstein | Underperform |
| Apr-03-24 | Initiated | William Blair | Mkt Perform |
| Mar-01-24 | Resumed | Goldman | Neutral |
| Nov-17-23 | Initiated | Piper Sandler | Neutral |
| Sep-11-23 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-07-23 | Initiated | Canaccord Genuity | Buy |
| Sep-06-23 | Initiated | Argus | Hold |
| Aug-24-23 | Upgrade | Goldman | Neutral → Buy |
| Jul-25-23 | Initiated | Edward Jones | Buy |
| Jun-01-23 | Initiated | HSBC Securities | Hold |
| May-30-23 | Initiated | BofA Securities | Buy |
| May-30-23 | Initiated | Citigroup | Neutral |
| May-30-23 | Initiated | Deutsche Bank | Hold |
| May-30-23 | Initiated | Exane BNP Paribas | Neutral |
| May-30-23 | Initiated | Goldman | Neutral |
| May-30-23 | Initiated | JP Morgan | Overweight |
| May-30-23 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Initiated | UBS | Neutral |
View All
Kenvue Inc Stock (KVUE) Latest News
Kenvue Inc. stock rises Friday, outperforms market - MarketWatch
The Technical Signals Behind (KVUE) That Institutions Follow - Stock Traders Daily
Kenvue stock slips 1.06 percent ahead of the open - AD HOC NEWS
Kenvue stock trades 11.9 percent below its yearly high - AD HOC NEWS
Andra AP fonden Acquires Shares of 210,900 Kenvue Inc. $KVUE - MarketBeat
Kimberly-Clark offers remedies in bid for EU approval of Kenvue deal - Reuters
EU extends review of Kimberly-Clark’s $40B Kenvue deal - TradingView
kimberly clark offers eu remedies for 40 billion kenvue deal - grafa.com
Kenvue stock rises as Kimberly Clark advances its takeover bid - AD HOC NEWS
Kimberly-Clark Offers Concessions for EU Approval of $40 Billion Kenvue Deal - marketscreener.com
Nykredit A S Acquires Shares of 235,332 Kenvue Inc. $KVUE - MarketBeat
Kenvue stock adds 1.1 percent ahead of the open - AD HOC NEWS
Kenvue Inc. (KVUE) Edges Higher as Shares Test Mid-Range ResistanceDaily Profile - siam.in
Kenvue Inc. stock rises Tuesday, outperforms market - MarketWatch
Kenvue stock gains 0.40 percent as dividend trading begins - AD HOC NEWS
Kenvue stock heads into the open after a 0.40% gain. - AD HOC NEWS
Kenvue stock trades ex-dividend as income focus grows - AD HOC NEWS
Kenvue’s Climate Transition Plan: Goals, Progress, and Strategy - CSRwire
Kenvue Inc's Dividend Analysis - Yahoo Finance
Kenvue stock heads into the open ex-dividend after a modest gain - AD HOC NEWS
Kenvue stock edges higher as quarterly earnings beat expectations - AD HOC NEWS
Engineers Gate Manager LP Reduces Stock Position in Kenvue Inc. $KVUE - MarketBeat
Kimberly-Clark Corporation - Britannica
Kenvue stock holds near deal-implied value as Kimberly-Clark acquisition advances - AD HOC NEWS
Former J&J Unit Beats Claims Its Sunscreen Caused Cancer - law360.com
Canaccord Genuity Keeps Their Buy Rating on Kenvue, Inc. (KVUE) - The Globe and Mail
Kenvue Inc. $KVUE Shares Sold by Corient Private Wealth LP - marketbeat.com
Better Dividend King to Buy and Hold: Johnson & Johnson or Kenvue? - Yahoo Finance
CCORF Upgrades Kenvue(KVUE.US) to Buy Rating - Moomoo
Neutrogena® launches new sunscreen technology with Cloud-Tech™A new view of care - Kenvue
14,401,068 Shares in Kenvue Inc. $KVUE Purchased by Bank of America Corp DE - MarketBeat
Kenvue stock heads into the open after closing near USD 17.97 - AD HOC NEWS
Kenvue Inc. $KVUE Holdings Increased by HBK Investments L P - MarketBeat
What's Going On With Kimberly-Clark Stock Wednesday?Kenvue (NYSE:KVUE), Kimberly-Clark (NASDAQ:KMB) - Benzinga
Should Kenvue’s (KVUE) TYLENOL with Naproxen Launch and Dividend Plan Prompt Investor Reassessment? - finance.yahoo.com
Kimberly-Clark Moves to Clear EU Hurdle with Kenvue Asset Sales - Yahoo Finance
Kimberly-Clark expected to win EU approval for Kenvue in phase 1report - Seeking Alpha
Kenvue Inc. (KVUE) Stock Forecasts - finance.yahoo.com
Kenvue Inc. $KVUE Shares Sold by California State Teachers Retirement System - MarketBeat
Kimberly-Clark preps for asset sale tied to $48B Kenvue purchase - The Business Journals
Kimberly-Clark weighs asset sales as EU reviews $40B Kenvue deal - TradingView
Kimberly-Clark readies EU remedies in bid for Kenvue deal, sources say - TradingView
Tylenol Maker Fights Ruling That Revived 500 Autism Lawsuits - Law Commentary
Kenvue stock heads into the open after a 1.8% gain - AD HOC NEWS
Sorbent to acquire Kenvue's Stayfree and Carefree business in Australia and New Zealand - Yahoo Finance
Is Kenvue Underperforming the Nasdaq? - inkl
Kimberly-Clark’s 54-Year Dividend Streak Faces Its Biggest Test Yet With $48.7 Billion Kenvue Deal - Yahoo Finance
What Is Driving Attention Around Kenvue (KVUE)? - Kalkine Media
Kenvue Inc. $KVUE Stake Lifted by Tidal Investments LLC - MarketBeat
National Pension Service Has $64.38 Million Holdings in Kenvue Inc. $KVUE - MarketBeat
The New York Stock Exchange | NYSE - NYSE
Kenvue Inc Stock (KVUE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):